Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification.
Ferro M, Rocco B, Maggi M, Lucarelli G, Falagario UG, Del Giudice F, Crocetto F, Barone B, La Civita E, Lasorsa F, Brescia A, Catellani M, Busetto GM, Tataru OS, Terracciano D. Ferro M, et al. Among authors: la civita e. Expert Rev Mol Diagn. 2023 Jul-Dec;23(12):1061-1070. doi: 10.1080/14737159.2023.2277366. Epub 2023 Dec 15. Expert Rev Mol Diagn. 2023. PMID: 37897252 Review.
Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer.
Ferro M, La Civita E, Liotti A, Cennamo M, Tortora F, Buonerba C, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F, de Cobelli O, Carrieri G, Porreca A, Cimmino A, Terracciano D. Ferro M, et al. Among authors: la civita e. J Pers Med. 2021 Mar 23;11(3):237. doi: 10.3390/jpm11030237. J Pers Med. 2021. PMID: 33806972 Free PMC article. Review.
Reply to Jue et al. Value of MRI to Improve Deep Learning Model That Identifies High-Grade Prostate Cancer. Comment on "Gentile et al. Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model. Diagnostics 2021, 11, 335".
Gentile F, Ferro M, Della Ventura B, La Civita E, Liotti A, Cennamo M, Bruzzese D, Velotta R, Terracciano D. Gentile F, et al. Among authors: la civita e. Diagnostics (Basel). 2021 Jul 6;11(7):1214. doi: 10.3390/diagnostics11071214. Diagnostics (Basel). 2021. PMID: 34359297 Free PMC article.
Liquid biopsy in bladder cancer: State of the art and future perspectives.
Crocetto F, Barone B, Ferro M, Busetto GM, La Civita E, Buonerba C, Di Lorenzo G, Terracciano D, Schalken JA. Crocetto F, et al. Among authors: la civita e. Crit Rev Oncol Hematol. 2022 Feb;170:103577. doi: 10.1016/j.critrevonc.2022.103577. Epub 2022 Jan 5. Crit Rev Oncol Hematol. 2022. PMID: 34999017 Review.
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy.
Ferro M, Tătaru OS, Musi G, Lucarelli G, Abu Farhan AR, Cantiello F, Damiano R, Hurle R, Contieri R, Busetto GM, Carrieri G, Cormio L, Del Giudice F, Sciarra A, Perdonà S, Borghesi M, Terrone C, La Civita E, Bove P, Autorino R, Muto M, Crisan N, Marchioni M, Schips L, Soria F, Terracciano D, Papalia R, Crocetto F, Barone B, Russo GI, Luzzago S, Ludovico GM, Vartolomei MD, Mistretta FA, Mirone V, de Cobelli O. Ferro M, et al. Among authors: la civita e. Diagnostics (Basel). 2022 Feb 25;12(3):586. doi: 10.3390/diagnostics12030586. Diagnostics (Basel). 2022. PMID: 35328139 Free PMC article.
A Combinatorial Neural Network Analysis Reveals a Synergistic Behaviour of Multiparametric Magnetic Resonance and Prostate Health Index in the Identification of Clinically Significant Prostate Cancer.
Gentile F, La Civita E, Della Ventura B, Ferro M, Cennamo M, Bruzzese D, Crocetto F, Velotta R, Terracciano D. Gentile F, et al. Among authors: la civita e. Clin Genitourin Cancer. 2022 Oct;20(5):e406-e410. doi: 10.1016/j.clgc.2022.04.013. Epub 2022 Apr 29. Clin Genitourin Cancer. 2022. PMID: 35610113
A Neural Network Model Combining [-2]proPSA, freePSA, Total PSA, Cathepsin D, and Thrombospondin-1 Showed Increased Accuracy in the Identification of Clinically Significant Prostate Cancer.
Gentile F, La Civita E, Ventura BD, Ferro M, Bruzzese D, Crocetto F, Tennstedt P, Steuber T, Velotta R, Terracciano D. Gentile F, et al. Among authors: la civita e. Cancers (Basel). 2023 Feb 21;15(5):1355. doi: 10.3390/cancers15051355. Cancers (Basel). 2023. PMID: 36900150 Free PMC article.
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings.
Ferro M, Lucarelli G, Crocetto F, Dolce P, Verde A, La Civita E, Zappavigna S, de Cobelli O, Di Lorenzo G, Facchini BA, Scafuri L, Onofrio L, Porreca A, Busetto GM, Sonpavde G, Caraglia M, Klain M, Terracciano D, De Placido S, Buonerba C. Ferro M, et al. Among authors: la civita e. Crit Rev Oncol Hematol. 2021 Jan;157:103198. doi: 10.1016/j.critrevonc.2020.103198. Epub 2020 Dec 13. Crit Rev Oncol Hematol. 2021. PMID: 33316417
31 results